Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-125327
Filing Date
2024-11-12
Accepted
2024-11-12 16:05:19
Documents
2
Period of Report
2024-11-11

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1602
2 EX-24 gern-ex24.htm EX-24 10502
  Complete submission text file 0000950170-24-125327.txt   13667
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BRISTOL-MYERS SQUIBB COMPANY 3401 PRINCETON PIKE LAWRENCEVILLE NJ 08648
Business Address
Eid Joseph (Reporting) CIK: 0001780247 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-20859 | Film No.: 241447954